BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancer
Guardado en:
Autores principales: | Scott Kopetz, Axel Grothey, Shifra Krinshpun, Meenakshi Malhotra, Paul Billings, Angel Rodriguez, Sarah Sawyer, Michelle Munro, Pashtoon Murtaza Kasi, Jessica Guilford, Sascha Ellers, Jacob Wulff, Nicole Hook, Allyson Koyen Malashevich, Solomon Moshkevich |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9887af290e0143cf93aa6bd064490660 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
por: John Yeakel, MD, et al.
Publicado: (2021) -
Data-Enriched Edible Pharmaceuticals (DEEP) with Bespoke Design, Dose and Drug Release
por: Meie Chao, et al.
Publicado: (2021) -
Assessing associations between socio-economic environment and self-reported health in Amsterdam using bespoke environments.
por: Eleonore M Veldhuizen, et al.
Publicado: (2013) -
Diabetic retinopathy. Results of international multicentre studies
por: Olga Mikhailovna Smirnova
Publicado: (2010) -
Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab
por: George P Kim, et al.
Publicado: (2008)